Continental announces new Grand Prix 5000 S TR – Gear
Continental has announced the launch of the Grand Prix 5000 S TR.
The new Grand Prix 5000 S TR is 20% faster and 50g lighter than the Grand Prix 5000 TL thanks to its 2-ply structure, with 28% more sidewall protection, specifies the brand. Available in black or black colourways and transparent sidewalls, the Grand Prix 5000 S TR uses Continental’s BlackChili compound for “the ultimate balance of rolling resistance, grip and longevity”, Vectran Breaker for puncture protection and strength tear, and Lazer Grip for “exceptional” cornering.
Rather than just updating the Grand Prix 5000 TL, Continental said it has “reinvented” its approach to tubeless-ready road tires. The Grand Prix 5000 S TR is hookless and tubeless ready as standard, thanks to a new user-optimized tubeless system and rugged construction.
Oliver Anhuth, TwoWheel Tires Marketing Manager, Continental, said: “Following the success of the Grand Prix 5000 – which has arguably become one of the world’s most beloved performance road tires – we are delighted to announce the launch of the Grand Prix 5000 S TR.
“We created this new tire to combine maximum performance with ease of use and reliability, whether the rider chooses to run, spend long days exploring the roads, ride in the summer or all year round. All-new hookless compatibility and tubeless capabilities will put uncompromising convenience at the heart of every rider’s ride.
The Grand Prix 5000 S TR was tested in training, racing and performance laboratories by several teams in the professional peloton in 2021. This season it has been ridden by Grand Tour stage winners and champions of the world, including that of Filippo Ganna (INEOS-Grenadiers) Victory of the world time trial championship in September as well as the victory of Sonny Colbrelli (Bahreïn-Victorious) at Paris-Roubaix.
This latest performance tire hits the market as Continental celebrates its 150th anniversary. The tire has been in development since 2019, with over 18 months of testing and trials completed.